Applied MaterialsvsHealth Catalyst

AMAT and HCAT stock compared: price, dividend, valuation and results, from SEC filings.

AMAT

Applied Materials, Inc.

$352.30

Value $279B

+0.88%
AMAT's page

HCAT

Health Catalyst, Inc

$1.29

Value $95M

-5.84%
HCAT's page

Applied Materials (AMAT) has a market value of $279B and Health Catalyst (HCAT) $95M. Over the last year, with dividends, AMAT moved +54.9% and HCAT -42.4%. Dividend yield: AMAT 0.56%, HCAT none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMAT$279B

    HCAT$95M

    AMAT is 2,943 times HCAT

  • Revenue, 12 months

    AMAT$30.8B

    HCAT$272M

    AMAT is 113 times HCAT

  • Net income, 12 months

    AMAT$9.3B

    HCAT-$202M

  • Operating margin

    AMAT29.6%

    HCAT-65.7%

    95.3 points apart

  • ROIC

    AMAT27.5%

    HCAT-44.9%

    72.3 points apart

  • P/E

    AMAT30.1

    HCAT–

  • Dividend yield

    AMAT0.6%

    HCAT0.0%

    0.6 points apart

  • 5-year return

    AMAT+135.4%

    HCAT-97.4%

    232.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMAT+135.4%

HCAT-97.4%

020040020222023202420252026
Returns by period
PeriodAMATWith dividendsHCATWith dividends
1 year since November 17, 2025+54.9%Price +54.0%-42.4%Price -42.4%
3 years since November 17, 2023+142.7%+34.4% a yearPrice +137.1%-83.4%-45.1% a yearPrice -83.4%
5 years since November 17, 2021+135.4%+18.7% a yearPrice +125.9%-97.4%-51.8% a yearPrice -97.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMATApplied MaterialsHCATHealth Catalyst

Valuation

AMATHCAT
Valuation
Price$352.30$1.29
Market value$279B$95M
Enterprise value (EV)$277B$16M
P/E30.1–
P/E, 5-year median21.4–
P/B10.90.7
EV/EBIT30.3–
Free cash flow yield2.0%27.1%

Results and growth

AMATHCAT
Results and growth
Revenue, 12 months$30.8B$272M
Net income, 12 months$9.3B-$202M
Free cash flow, 12 months$5.6B$26M
Earnings per share, 12 months$11.59-$2.85
Revenue growth, year on year4.4%1.5%
Revenue growth a year, past+10.5%over 5 years+10.5%over 5 years
EPS growth a year, past+17.2%over 5 years–

Margins and returns on capital

AMATHCAT
Margins and returns on capital
Gross margin49.4%49.1%
Operating margin29.6%-65.7%
Net margin30.0%-74.2%
ROIC27.5%-44.9%
ROE41.7%-105.0%

Balance sheet

AMATHCAT
Balance sheet
Cash$9.2B$79M
Total debt$7.3B$16M
Net debt / EBITDA-0.3–
Interest cover33.0×–

Dividends and buybacks

AMATHCAT
Dividends and buybacks
Dividend yield0.6%–
Dividend per share, 12 months$1.98–
Dividend growth a year, past+15.4%over 5 years–
Buyback yield1.8%5.3%
Shareholder yield2.3%5.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMAT or HCAT

Didn't find what you were looking for?

Ask us
Which is bigger, Applied Materials or Health Catalyst?

By market value, Applied Materials ($279B) is about 2,942.9 times Health Catalyst ($95M), at today's prices.

How did AMAT and HCAT stock do over the last 5 years?

Since November 17, 2021, AMAT's price moved +125.9% and HCAT's -97.4%. With dividends: AMAT +135.4% (+18.7% a year), HCAT -97.4% (-51.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMAT or HCAT?

The dividend yield at today's price is 0.56% for Applied Materials and none for Health Catalyst. Over the last twelve months they paid $1.98 and – per share.

Which has the higher profit margins, Applied Materials or Health Catalyst?

Over the last twelve months, the net margin was 30.0% for Applied Materials and -74.2% for Health Catalyst, and the operating margin 29.6% and -65.7%. Revenue was $30.8B and $272M.

Which is the better investment, Applied Materials or Health Catalyst?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.